ReviewAdvances in biological regulation2020
Cancer therapy and treatments during COVID-19 era.
Review in Advances in biological regulation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.
- Psychological Distress Among Cancer Patients During COVID-19 Pandemic in the World: A Systematic Review.Frontiers in psychology · 2021Pooled it
- COVID-19-Related Treatment Cancellations and Oncology Patients' Psychological Health in Nigeria.Clinical medicine & research · 2024Article
- The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients.Journal of gastrointestinal cancer · 2023Article
- Coronaphobia: A barrier to ongoing cancer treatment?Psycho-oncology · 2022Article
- Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review).International journal of oncology · 2022Article
- Dynamical demeanour of SARS-CoV-2 virus undergoing immune response mechanism in COVID-19 pandemic.The European physical journal. Special topics · 2022Article
- Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer.Journal of clinical medicine · 2021Article
- Global dynamics of SARS-CoV-2/cancer model with immune responses.Applied mathematics and computation · 2021Article
- Neglected malignant neoplasms with cutaneous involvement.Postepy dermatologii i alergologii · 2021Article
- Comparison of Colorectal Cancer Surgery Services During COVID-19 First Wave With Pre-COVID Time.Cureus · 2021Article
- Coronavirus (COVID-19): A Systematic Review and Meta-analysis to Evaluate the Significance of Demographics and Comorbidities.Research square · 2021Article
- Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges.Frontiers in microbiology · 2021Review
- Immuno-oncologic care during COVID-19: Challenges and opportunities for improving clinical care and investigation.Journal of cancer biology · 2021Article
- More Aggressive Cancer Behaviour in Thyroid Cancer Patients in the Post-COVID-19 Pandemic Era: A Retrospective Study.International journal of general medicine · 2021Article
- Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.Oncology and therapy · 2020Article
- Cancer Imaging and Patient Care during the COVID-19 Pandemic.Radiology. Imaging cancer · 2020Review
- Foreword for the special issue advances in COVID-19: Biology and clinic.Advances in biological regulation · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 8 institutions in 3 countries.
Funding
Abstract
The COVID-19 pandemic has put a serious strain on health treatments as well at the economies of many nations. Unfortunately, there is not currently available vaccine for SARS-Cov-2/COVID-19. Various types of patients have delayed treatment or even routine check-ups and we are adapting to a virtual world. In many cases, surgeries are delayed unless they are essential. This is also true with regards to cancer treatments and screening. Interestingly, some existing drugs and nutraceuticals have been screened for their effects on COVID-19. Certain FDA approved drugs, vitamin, natural products and trace minerals may be repurposed to treat or improve the prevention of COVID-19 infections and disease progression. This review article will summarize how the treatments of various cancer patients has changed during the COVID-19 era as well as discuss the promise of some existing drugs and other agents to be repurposed to treat this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.